CSIMarket
 
Zenas Biopharma Inc   (NASDAQ: ZBIO)

Zenas Biopharma Inc

Officers & Directors




Zenas Biopharma Inc currently has 167 employees.

  News about Zenas Biopharma Inc Key Personnel

Zenas BioPharma Under Fire: Stock Options for New Executives Amid Financial Woes and Legal Scrutiny,

Zenas BioPharma s Stock Options Riddle Amid Financial ScrutinyBy Author Name | CSI MarketApril 18, 2025 — In a move that has raised eyebrows within the biopharmaceutical community, Zenas BioPharma, Inc. (Nasdaq: ZBIO) announced on April 15, 2025, the granting of nonqualified stock options to two newly hired executives. This decision was made in accordance with Nasdaq’s Listing Rule 5635(c)(4) and purportedly serves as an inducement for these officers to join the company. Yet, this announcement arrives amid growing concern over the company s financial health and potential discrepancies in its disclosed information which have triggered a burgeoning investigation by The Rosen Law Firm into its securities...






ZBIO Management Effectiveness ZBIO Revenue per Employee ZBIO Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.